Rezolute (RZLT) Invested Capital (2011 - 2022)

Rezolute (RZLT) posted Invested Capital of $15.7 million for Q1 2022, little changed sequentially from $15.7 million in Q4 2021.

Analysis

Rezolute (RZLT) Invested Capital (2011 - 2022) Analysis & Trends

Rezolute has reported Invested Capital for 8 years, with the latest figure at $15.7 million in Q1 2022.

Quarterly Invested Capital changed N/A year-over-year to $15.7 million in Q1 2022, while the trailing twelve-month figure through Dec 2022 was $15.7 million (down 66.66% YoY) and the FY2021 annual result came in at $15.7 million, changed N/A from the prior year.
Invested Capital steadied at $15.7 million in Q1 2022 per RZLT's latest filing, from $15.7 million in the prior quarter.
Over five years, Invested Capital peaked at $15.7 million in Q2 2021 and troughed at $15.7 million in Q4 2021.

Peer Set

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Invested Cap. (Qtr)
1	Vertex Pharmaceuticals	138.47 Bn	130.62 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	85.18 Bn	77.19 Bn	3.93 Bn	33.70 Bn
3	Argenx Se	63.38 Bn	58.19 Bn	1.37 Bn	-
4	Moderna	58.09 Bn	52.95 Bn	52.00 Mn	7.35 Bn
5	Revolution Medicines	44.33 Bn	44.33 Bn	-	-
6	BeOne Medicines	40.02 Bn	34.92 Bn	1.53 Bn	6.25 Bn
7	Alnylam Pharmaceuticals	35.57 Bn	32.27 Bn	992.69 Mn	-
8	Royalty Pharma	28.45 Bn	27.61 Bn	-	19.13 Bn
9	Insmed	27.48 Bn	26.32 Bn	358.27 Mn	1.30 Bn
10	Rezolute	477.02 Mn	477.02 Mn	-	-

Historic Data

Download Data